Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $8.08 down -2.06% from its previous closing price of $8.25. In other words, the price has decreased by -$2.06 from its previous closing price. On the day, 1.49 million shares were traded. ORIC stock price reached its highest trading level at $8.33 during the session, while it also had its lowest trading level at $7.955.
Ratios:
For a deeper understanding of ORIC Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.65 and its Current Ratio is at 14.65. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Evercore ISI on November 20, 2025, initiated with a Outperform rating and assigned the stock a target price of $25.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 16 ’25 when Multani Pratik S sold 10,720 shares for $9.06 per share. The transaction valued at 97,129 led to the insider holds 68,149 shares of the business.
Piscitelli Dominic sold 10,720 shares of ORIC for $97,127 on Dec 16 ’25. The Chief Financial Officer now owns 68,148 shares after completing the transaction at $9.06 per share. On Dec 16 ’25, another insider, Chacko Jacob, who serves as the PRESIDENT AND CEO of the company, sold 33,374 shares for $9.06 each. As a result, the insider received 302,368 and left with 581,711 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 786905344 and an Enterprise Value of 507160384.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.34, which has changed by -0.0012106299 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.93, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is -27.38%, while the 200-Day Moving Average is calculated to be -14.66%.
Shares Statistics:
For the past three months, ORIC has traded an average of 1.37M shares per day and 1626400 over the past ten days. A total of 97.28M shares are outstanding, with a floating share count of 54.17M. Insiders hold about 44.38% of the company’s shares, while institutions hold 68.87% stake in the company. Shares short for ORIC as of 1765756800 were 17956700 with a Short Ratio of 13.13, compared to 1763078400 on 16253539. Therefore, it implies a Short% of Shares Outstanding of 17956700 and a Short% of Float of 18.67.
Earnings Estimates
A detailed examination of ORIC Pharmaceuticals Inc (ORIC) is currently in progress, with 13.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.3 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$1.48 and -$2.41 for the fiscal current year, implying an average EPS of -$1.63. EPS for the following year is -$1.57, with 13.0 analysts recommending between -$1.22 and -$2.54.
